Overactive Bladder - Results from #660

Safety and effectiveness of mirabegron in male patients with overactive bladder with or without benign prostatic hyperplasia: A Japanese post-marketing study. August 14, 2020

Comparison of the effects of trospium and solifenacin on intraocular pressure and tear secretion in patients with overactive bladder. August 7, 2020

[Treatment of idiopathic overactive bladder in women: Transcutaneous tibial nerve stimulation alone versus combined with pelvic floor muscle training]. August 7, 2020

Effect of electroacupuncture versus solifenacin for moderate and severe overactive bladder: a multi-centre, randomized controlled trial study protocol. August 7, 2020

Protocol for a multicenter randomized, double blind, controlled pilot trial of higher neural function in overactive bladder patients after anticholinergic, beta-3 adrenergic agonist, or placebo. August 1, 2020

Clinical outcomes of sacral neuromodulation in non-neurogenic, non-obstructive dysuria: A 5-year retrospective, multicentre study in China. August 1, 2020

Safety and Tolerability Results from the PILLAR Study: A Phase IV, Double-Blind, Randomized, Placebo-Controlled Study of Mirabegron in Patients ≥ 65 years with Overactive Bladder-Wet. August 1, 2020

Evaluation of pupil responses and anterior chamber parameters in overactive bladder syndrome before and after antimuscarinic treatment. August 1, 2020

OnabotulinumtoxinA is a well tolerated and effective treatment for refractory overactive bladder in real-world practice. August 1, 2020

A Supervised Three Weeks Test Phase in Sacral Neuromodulation with a One-Year Follow-Up. August 1, 2020

Correlation between Overactive Bladder Syndrome and Severity of Coronary Artery Disease in Postmenopausal Women. August 1, 2020

[Botulinum toxin for overactive bladder]. July 26, 2020

Botox rechallenge-An additional tool in the management of an incompletely emptying bladder and inadequate overactive symptom control following sacral neuromodulation. July 26, 2020

[Knowledge, practices and expectations in the management of overactive bladder in general practice and gynecology in France]. July 26, 2020

[Analysis of costs and consequences related to the persistence of Mirabegron and antimuscarinic treatments and their impact on quality of life in patients with overactive bladder in Spain: Results of a probabilistic model.] July 26, 2020

Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis. July 25, 2020

Treatment for refractory overactive bladder: a systematic review and meta-analysis of sacral neuromodulation and onabotulinumtoxinA. July 19, 2020

Taking OAB Seriously: A Qualitative Evaluation of Primary Care Education on Overactive Bladder Syndrome Management. July 19, 2020

[Symptoms severity profile and expectations in hyperactive bladder patients - VHEXPECTA Study.] July 19, 2020

Medicinal Plants Used To Treat Overactive Bladder. July 19, 2020

Page 34 of 122